- Home
- GILD vs SHOP Comparison
GILD vs SHOP Comparison
Compare GILD & SHOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- SHOP
- Stock Information
- Founded
- GILD 1987
- SHOP 2004
- Country
- GILD United States
- SHOP Canada
- Employees
- GILD N/A
- SHOP N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- SHOP Computer Software: Prepackaged Software
- Sector
- GILD Health Care
- SHOP Technology
- Exchange
- GILD Nasdaq
- SHOP Nasdaq
- Market Cap
- GILD 138.2B
- SHOP 122.8B
- IPO Year
- GILD 1992
- SHOP 2015
- Fundamental
- Price
- GILD $111.79
- SHOP $96.70
- Analyst Decision
- GILD Buy
- SHOP Buy
- Analyst Count
- GILD 27
- SHOP 33
- Target Price
- GILD $105.32
- SHOP $116.71
- AVG Volume (30 Days)
- GILD 10.7M
- SHOP 10.1M
- Earning Date
- GILD 04-24-2025
- SHOP 05-07-2025
- Dividend Yield
- GILD 2.83%
- SHOP N/A
- EPS Growth
- GILD N/A
- SHOP 1409.81
- EPS
- GILD 0.38
- SHOP 1.55
- Revenue
- GILD $28,754,000,000.00
- SHOP $8,880,000,000.00
- Revenue This Year
- GILD $1.77
- SHOP $25.38
- Revenue Next Year
- GILD $3.52
- SHOP $20.56
- P/E Ratio
- GILD $294.18
- SHOP $62.37
- Revenue Growth
- GILD 6.04
- SHOP 25.78
- 52 Week Low
- GILD $62.07
- SHOP $48.56
- 52 Week High
- GILD $119.96
- SHOP $129.38
- Technical
- Relative Strength Index (RSI)
- GILD 57.43
- SHOP 41.53
- Support Level
- GILD $104.70
- SHOP $92.91
- Resistance Level
- GILD $107.42
- SHOP $111.00
- Average True Range (ATR)
- GILD 2.48
- SHOP 4.39
- MACD
- GILD -0.62
- SHOP 0.78
- Stochastic Oscillator
- GILD 57.74
- SHOP 34.70
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About SHOP Shopify Inc.
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.